DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Maxipime (Cefepime) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Maxipime (Cefepime). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (46)
     Convulsion (6)Haematuria (5)Condition Aggravated (5)more >>

Cases resulting in a serious event (41)
     Convulsion (6)Haematuria (5)Condition Aggravated (5)more >>

Cases resulting in death (13)
     Multi-Organ Failure (4)Anaphylactic Shock (3)Convulsion (3)more >>

Cases resulting in life threatening events (6)
     Convulsion (3)White Blood Cell Count Decreased (2)Blood Urea Increased (2)more >>

Cases resulting in hospitalization (21)
     Haematuria (5)Condition Aggravated (5)C-Reactive Protein Increased (5)more >>

Cases resulting in disability (1)
     Strabismus (1)Convulsion (1)Depressed Level of Consciousness (1)

Cases resulting in other serious reactions (7)
     Hepatic Function Abnormal (1)Vomiting (1)Drug Ineffective (1)more >>

Below is a sample of reports where side effects / adverse reactions may be related to Maxipime (Cefepime). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in female receiving Maxipime (Cefepime)

Reported by a physician from Japan on 2007-10-26

Patient: female, weighing 47.0 kg (103.4 pounds)

Adverse reactions / side effects: Interstitial Lung Disease, Febrile Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Farmorubicin RD
    Dosage: daily dose:120mg-freq:every days
    Indication: Breast Cancer

Farmorubicin RD
    Dosage: daily dose:90-freq:every days

Endoxan
    Dosage: daily dose:900mg-freq:every days
    Indication: Breast Cancer

Endoxan
    Dosage: daily dose:700mg-freq:every days

Gran
    Dosage: daily dose:75mcg-freq:every days

Maxipime
    Dosage: daily dose:2000mg
    Start date: 2007-09-17
    End date: 2007-09-19



Adverse event in 58 year old male receiving Maxipime (Cefepime)

Reported by a individual with unspecified qualification from Japan on 2007-10-19

Patient: 58 year old male

Adverse reactions / side effects: Jaundice, Gastrointestinal Haemorrhage, Leukaemia Recurrent, Hypokalaemia, Haematemesis, Disease Progression, Liver Disorder, Blood Uric Acid Decreased, Blood Lactate Dehydrogenase Increased, Acute Myeloid Leukaemia, Anaemia, Haematuria, Febrile Neutropenia, Condition Aggravated, Hypoproteinaemia, Platelet Count Decreased, Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Novantrone
    Dosage: see image
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2007-03-29
    End date: 2007-03-30

Novantrone
    Dosage: see image
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2007-03-30
    End date: 2007-03-30

Novantrone
    Dosage: see image
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2007-04-13
    End date: 2007-04-13

Novantrone
    Dosage: see image
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2007-04-25
    End date: 2007-04-25

Mylotarg
    Dosage: see image
    Start date: 2007-03-02
    End date: 2007-03-02

Mylotarg
    Dosage: see image
    Start date: 2007-03-16
    End date: 2007-03-16

Itraconazole
    Dosage: 200 mg, 1 in 1 days, intravenous (not otherwise specified)
    Start date: 2007-03-23
    End date: 2007-04-05

Maxipime
    Dosage: see image
    Start date: 2007-03-07
    End date: 2007-03-12

Maxipime
    Dosage: see image
    Start date: 2007-03-18
    End date: 2007-03-31

Other drugs received by patient: Idarubicin HCL



Adverse event in male receiving Maxipime (Cefepime)

Reported by a physician from Japan on 2007-10-10

Patient: male, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Jaundice, Gastrointestinal Haemorrhage, Malignant Neoplasm Progression, Liver Disorder, Hypokalaemia, Haematemesis, Blood Uric Acid Decreased, C-Reactive Protein Increased, Blood Lactate Dehydrogenase Increased, Acute Myeloid Leukaemia, Anaemia, Haematuria, Febrile Neutropenia, Condition Aggravated, Hypoproteinaemia, Platelet Count Decreased, Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Mylotarg
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2007-03-02
    End date: 2007-03-02

Mylotarg
    Start date: 2007-03-16
    End date: 2007-03-16

Itrizole
    Start date: 2007-03-23
    End date: 2007-04-05

Maxipime
    Start date: 2007-03-07
    End date: 2007-03-12

Maxipime
    Start date: 2007-03-18
    End date: 2007-03-31

Novantrone
    Dosage: unknown
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2007-03-29
    End date: 2007-03-30

Novantrone
    Dosage: unknown
    Start date: 2007-03-30
    End date: 2007-03-30

Novantrone
    Dosage: unknown
    Start date: 2007-04-13
    End date: 2007-04-13

Novantrone
    Dosage: unknown
    Start date: 2007-04-25
    End date: 2007-04-25

Other drugs received by patient: Idamycin



Adverse event in 65 year old female receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-03

Patient: 65 year old female

Adverse reactions / side effects: Interstitial Lung Disease

Adverse event resulted in: life threatening event

Suspect drug(s):
Maxipime
    Indication: Febrile Neutropenia

Endoxan

Epirubicin

Gran



Adverse event in 65 year old female receiving Maxipime (Cefepime)

Reported by a physician from Japan on 2007-10-02

Patient: 65 year old female

Adverse reactions / side effects: Interstitial Lung Disease

Adverse event resulted in: hospitalization

Suspect drug(s):
Farmorubicin RD
    Indication: Breast Cancer

Endoxan
    Indication: Breast Cancer

Gran

Maxipime



Adverse event in 64 year old female receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-31

Patient: 64 year old female

Adverse reactions / side effects: C-Reactive Protein Increased, Pancytopenia, Pyrexia

Adverse event resulted in: hospitalization

Suspect drug(s):
Tagamet
    Start date: 2007-06-13
    End date: 2007-06-22

Omeprazole
    Start date: 2007-05-22
    End date: 2007-06-12

Ciprofloxacin
    Start date: 2007-06-12
    End date: 2007-06-15

Prodif
    Start date: 2007-06-13
    End date: 2007-06-18

Vancomycin Hydrochloride
    Start date: 2007-06-13
    End date: 2007-06-14

Maxipime
    Start date: 2007-06-15
    End date: 2007-06-18

Other drugs received by patient: Gran; Predonine



Adverse event in 64 year old female receiving Maxipime (Cefepime)

Reported by a physician from Japan on 2007-07-30

Patient: 64 year old female, weighing 57.0 kg (125.4 pounds)

Adverse reactions / side effects: Agranulocytosis, C-Reactive Protein Increased, Small Intestine Carcinoma, Hyponatraemia, Pancytopenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Zantac 150
    Dosage: 150mg per day
    Indication: Gastric Ulcer Haemorrhage
    Start date: 2007-06-13
    End date: 2007-06-28

Maxipime
    Dosage: 1g twice per day
    Indication: Sepsis
    Start date: 2007-06-15
    End date: 2007-06-18

Prodif
    Dosage: 400mg per day
    Indication: Sepsis
    Start date: 2007-06-13
    End date: 2007-06-18

Vancomycin
    Indication: Sepsis
    Start date: 2007-06-13
    End date: 2007-06-14

Other drugs received by patient: Omeprazole; Ciprofloxacin; Predonine; Tagamet; Hydrocortone; Predonine; Gran



Adverse event in 64 year old female receiving Maxipime (Cefepime)

Reported by a physician from Japan on 2007-07-27

Patient: 64 year old female, weighing 57.0 kg (125.4 pounds)

Adverse reactions / side effects: Agranulocytosis, C-Reactive Protein Increased, Small Intestine Carcinoma, Pancytopenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Zantac 150
    Dosage: 150mg per day
    Indication: Gastric Ulcer Haemorrhage
    Start date: 2007-06-13
    End date: 2007-06-28

Maxipime
    Dosage: 1g twice per day
    Indication: Sepsis
    Start date: 2007-06-15
    End date: 2007-06-18

Prodif
    Dosage: 400mg per day
    Indication: Sepsis
    Start date: 2007-06-13
    End date: 2007-06-18

Vancomycin
    Indication: Sepsis
    Start date: 2007-06-13
    End date: 2007-06-14

Other drugs received by patient: Omeprazole; Ciprofloxacin; Predonine; Tagamet; Hydrocortone; Predonine; Gran



Adverse event in male receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-26

Patient: male

Adverse reactions / side effects: Thrombocytopenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Maxipime (Cefepime)



Adverse event in 80 year old male receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-26

Patient: 80 year old male

Adverse reactions / side effects: Confusional State

Suspect drug(s):
Maxipime (Cefepime)

Other drugs received by patient: Vancomycin; Coreg; Ranitidine



Adverse event in receiving Maxipime (Cefepime)

Reported by a consumer/non-health professional from United States on 2007-07-26

Patient:

Adverse reactions / side effects: Neutropenia, White Blood Cell Count Increased

Suspect drug(s):
Maxipime (Cefepime)



Adverse event in 48 year old male receiving Maxipime (Cefepime)

Reported by a consumer/non-health professional from Singapore on 2007-07-25

Patient: 48 year old male

Adverse reactions / side effects: Drug Ineffective, Sepsis

Adverse event resulted in: death

Suspect drug(s):
Maxipime (Cefepime)

Other drugs received by patient: Meronem; Ciproxin



Adverse event in female receiving Maxipime (Cefepime)

Reported by a physician from Mexico on 2007-07-13

Patient: female

Adverse reactions / side effects: Drug Ineffective, Cardiac Arrest

Adverse event resulted in: death

Suspect drug(s):
Maxipime (Cefepime)

Other drugs received by patient: Platelets; Plasma; Vitamin K



Adverse event in 52 year old female receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-10

Patient: 52 year old female, weighing 43.7 kg (96.1 pounds)

Adverse reactions / side effects: Hepatic Function Abnormal

Suspect drug(s):
Meropenem
    Indication: Neutrophil Count Decreased
    Start date: 2007-04-15
    End date: 2007-04-16

Zovirax
    Administration route: Oral
    Indication: Herpes Zoster
    Start date: 2007-04-05
    End date: 2007-04-16

Neutrogin
    Indication: Stem Cell Transplant
    Start date: 2007-04-07
    End date: 2007-04-16

Maxipime
    Indication: Neutrophil Count Decreased
    Start date: 2007-04-08
    End date: 2007-04-15

Exacin Injection 400
    Indication: Neutrophil Count Decreased
    Start date: 2007-04-08
    End date: 2007-04-15

Targocid
    Indication: Neutrophil Count Decreased
    Start date: 2007-04-15
    End date: 2007-04-16

Other drugs received by patient: Bonalon Tablet; Estriel; Diflucan; Mucosta; Takepron; Pantosin; Magnesium Oxide; Depas; Fulcaliq No.1; Platelets; Platelets; RBC Concentrate Transfusion



Adverse event in 64 year old male receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-06-28

Patient: 64 year old male

Adverse reactions / side effects: Blood Bilirubin Increased, White Blood Cell Count Decreased, Blood Urea Increased, Alanine Aminotransferase Increased, Blood Potassium Increased, Condition Aggravated, Convulsion, Liver Disorder, Leukaemia, Multi-Organ Failure, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Creatinine Increased

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Ambisome
    Dosage: 150 mg, uid/qd, iv drip
    Indication: Fungal Infection
    Start date: 2007-05-03
    End date: 2007-05-15

Ciproflaxacin
    Dosage: 600 mg, uid/qd, iv drip
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-04-27
    End date: 2007-05-08

Targocid
    Dosage: 400 mg, uid/qd, iv drip
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-04-27
    End date: 2007-05-10

Potassium Chloride
    Dosage: see image
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-02
    End date: 2007-05-02

Potassium Chloride
    Dosage: see image
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-03
    End date: 2007-05-05

Potassium Chloride
    Dosage: see image
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-06
    End date: 2007-05-13

Maxipime
    Dosage: 4 g, uid/qd, iv nos
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-09
    End date: 2007-05-15

Zyvox
    Dosage: uid/qd, iv drip
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-11
    End date: 2007-05-15

Other drugs received by patient: Vfend; Platelets; RED Blood Cells; Neutrogin (Lenograstim); Physio (Glucose, Sodium Acetate, Calcium Gluconate, Sodium Chloride, P; Fulcaliq; Rituxan



Adverse event in 95 year old female receiving Maxipime (Cefepime)

Reported by a physician from Japan on 2007-06-22

Patient: 95 year old female

Adverse reactions / side effects: Depressed Level of Consciousness, Strabismus, Convulsion

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Maxipime (Cefepime)



Adverse event in 64 year old male receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-06-20

Patient: 64 year old male

Adverse reactions / side effects: Blood Bilirubin Increased, White Blood Cell Count Decreased, Blood Urea Increased, Alanine Aminotransferase Increased, Blood Potassium Increased, Condition Aggravated, Convulsion, Liver Disorder, Leukaemia, Multi-Organ Failure, Aspartate Aminotransferase Increased, Lung Cancer Metastatic, Platelet Count Decreased, Blood Creatinine Increased

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Ambisome
    Dosage: 150 mg, uid/qd, iv drip
    Indication: Fungal Infection
    Start date: 2007-05-03
    End date: 2007-05-15

Ciprofloxacin HCL
    Dosage: 600 mg, uid/qd, iv drip
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-04-27
    End date: 2007-05-08

Targocid
    Dosage: 400 mg, uid/qd, iv drip
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-04-27
    End date: 2007-05-10

Potassium Chloride
    Dosage: see image
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-02
    End date: 2007-05-02

Potassium Chloride
    Dosage: see image
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-03
    End date: 2007-05-05

Potassium Chloride
    Dosage: see image
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-06
    End date: 2007-05-13

Maxipime
    Dosage: 4 g, uid/qd, iv nos
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-09
    End date: 2007-05-15

Zyvox
    Dosage: uid/qd, iv drip
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-11
    End date: 2007-05-15

Other drugs received by patient: Vfend; Platelets; RED Blood Cells; Neutrogin (Lenograstim); Physio (Glucose, Sodium Acetate, Calcium Gluconate, Sodium Chloride,; Fulcaliq; Rituxan



Adverse event in male receiving Maxipime (Cefepime)

Reported by a physician from Japan on 2007-05-15

Patient: male, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Blast Cell Count Increased, Haematuria, Anaemia, Blood Lactate Dehydrogenase Increased, Condition Aggravated, Hypokalaemia, C-Reactive Protein Increased, Platelet Count Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Mylotarg
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2007-03-02
    End date: 2007-03-02

Mylotarg
    Start date: 2007-03-16
    End date: 2007-03-16

Itraconazole
    Start date: 2007-03-23
    End date: 2007-04-05

Maxipime
    Start date: 2007-03-07
    End date: 2007-03-12

Maxipime
    Start date: 2007-03-18
    End date: 2007-03-31

Other drugs received by patient: Idamycin; Novantrone



Adverse event in 77 year old female receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-14

Patient: 77 year old female

Adverse reactions / side effects: Ventricular Tachycardia, Convulsion

Adverse event resulted in: life threatening event

Suspect drug(s):
Maxipime (Cefepime)

Other drugs received by patient: Sigmart; Hustazol; Gramalil; Takepron; Aspirin; Hirnamin; Frandol Tape S; Procylin



Adverse event in 34 year old female receiving Maxipime (Cefepime)

Reported by a pharmacist from United States on 2007-05-08

Patient: 34 year old female, weighing 77.1 kg (169.6 pounds)

Adverse reactions / side effects: Burning Sensation, Rash, Infusion Related Reaction

Suspect drug(s):
Maxipime (Cefepime)



Adverse event in 83 year old female receiving Maxipime (Cefepime)

Reported by a physician from Austria on 2007-05-04

Patient: 83 year old female

Adverse reactions / side effects: Cardiac Failure

Adverse event resulted in: death

Suspect drug(s):
Maxipime (Cefepime)



Adverse event in 65 year old male receiving Maxipime (Cefepime)

Reported by a physician from Austria on 2007-05-04

Patient: 65 year old male, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Maxipime
    Indication: Respiratory Tract Infection
    Start date: 2001-12-21
    End date: 2001-12-24

Maxipime
    Indication: Wound
    Start date: 2001-12-21
    End date: 2001-12-24

Maxipime
    Indication: Sepsis
    Start date: 2001-12-21
    End date: 2001-12-24

Ciprofloxacin Hydrochloride
    Indication: Respiratory Tract Infection
    Start date: 2001-12-21
    End date: 2001-12-24

Ciprofloxacin Hydrochloride
    Indication: Sepsis
    Start date: 2001-12-21
    End date: 2001-12-24

Ciprofloxacin Hydrochloride
    Indication: Wound
    Start date: 2001-12-21
    End date: 2001-12-24



Adverse event in 77 year old female receiving Maxipime (Cefepime)

Reported by a physician from Austria on 2007-05-04

Patient: 77 year old female, weighing 120.0 kg (264.0 pounds)

Adverse reactions / side effects: Multi-Organ Failure

Adverse event resulted in: death

Suspect drug(s):
Maxipime
    Indication: Lung Infection
    Start date: 2004-01-17
    End date: 2004-01-22

Maxipime
    Indication: Genitourinary Tract Infection
    Start date: 2004-01-17
    End date: 2004-01-22

Gentamicin
    Indication: Lung Infection
    Start date: 2004-01-17
    End date: 2004-01-22

Gentamicin
    Indication: Genitourinary Tract Infection
    Start date: 2004-01-17
    End date: 2004-01-22



Adverse event in 82 year old female receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from Austria on 2007-05-04

Patient: 82 year old female, weighing 115.0 kg (253.0 pounds)

Adverse reactions / side effects: Multimorbidity

Adverse event resulted in: death

Suspect drug(s):
Maxipime
    Indication: Respiratory Tract Infection
    Start date: 2004-04-10
    End date: 2004-04-20

Maxipime
    Indication: Abdominal Infection
    Start date: 2004-04-10
    End date: 2004-04-20

Zyvox
    Indication: Abdominal Infection
    Start date: 2004-04-10
    End date: 2004-04-20

Zyvox
    Indication: Respiratory Tract Infection
    Start date: 2004-04-10
    End date: 2004-04-20



Adverse event in male receiving Maxipime (Cefepime)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-30

Patient: male, weighing 192.8 kg (424.1 pounds)

Adverse reactions / side effects: Rash Generalised

Suspect drug(s):
Maxipime
    Dosage: 1gm every 12 hours picc line
    Indication: Cellulitis
    Start date: 2007-04-21
    End date: 2007-04-24

Vancomycin
    Dosage: 1500mg every 12 hours picc line

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009